The Changing Face of Liver Transplantation in the United States: The Effect of HCV Antiviral Eras on Transplantation Trends and Outcomes

The Changing Face of Liver Transplantation in the United States: The Effect of HCV Antiviral Eras on Transplantation Trends and Outcomes

Background. Hepatitis C virus (HCV) cirrhosis is the leading indication for liver transplantation in the United States, although nonalcoholic steatohepatitis (NASH) is on the rise. Increasingly effective HCV antivirals are available, but their association with diagnosis-specific liver transplantatio...

Full description

Bibliographic Details
Main Authors: Nicholas F. Parrish, MD, PhD, Irene D. Feurer, PhD, Lea K. Matsuoka, MD, Scott A. Rega, MS, Roman Perri, MD, Sophoclis P. Alexopoulos, MD
Format: Article
Language:English
Published: Wolters Kluwer 2019-03-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000866

Internet

http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000866

Similar Items